Deoxycholate induces mitochondrial oxidative stress and activates NF-kappaB through multiple mechanisms in HCT-116 colon epithelial cells

Carcinogenesis. 2007 Jan;28(1):215-22. doi: 10.1093/carcin/bgl139. Epub 2006 Aug 3.

Abstract

Nuclear factor kappa B (NF-kappaB) is a redox-associated transcription factor that is involved in the activation of survival pathways. We have previously shown that deoxycholate (DOC) activates NF-kappaB in hepatocytes and colon epithelial cells and that persistent exposure of HCT-116 cells to increasing concentrations of DOC results in the constitutive activation of NF-kappaB, which is associated with the development of apoptosis resistance. The mechanisms by which DOC activates NF-kappaB in colon epithelial cells, and whether natural antioxidants can reduce DOC-induced NF-kappaB activation, however, are not known. Also, it is not known if DOC can generate reactive oxygen species within mitochondria as a possible pathway of stress-related NF-kappaB activation. Since we have previously shown that DOC activates the NF-kappaB stress-response pathway in HCT-116 cells, we used this cell line to further explore the mechanisms of NF-kappaB activation. We found that DOC induces mitochondrial oxidative stress and activates NF-kappaB in HCT-116 cells through multiple mechanisms involving NAD(P)H oxidase, Na+/K+-ATPase, cytochrome P450, Ca++ and the terminal mitochondrial respiratory complex IV. DOC-induced NF-kappaB activation was significantly (P < 0.05) inhibited by pre-treatment of cells with CAPE, EGCG, TMS, DPI, NaN3, EGTA, Ouabain and RuR. The NF-kappaB-activating pathways, induced by the dietary-related endogenous detergent DOC, provide mechanisms for promotion of colon cancer and identify possible new targets for chemoprevention.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antioxidants / pharmacology
  • Calcium / metabolism
  • Cytochrome P-450 Enzyme System / metabolism
  • Deoxycholic Acid / pharmacology*
  • Detergents / pharmacology*
  • Electron Transport Complex IV / metabolism
  • HCT116 Cells / drug effects
  • Humans
  • Membrane Potential, Mitochondrial / drug effects*
  • NADPH Oxidases / metabolism
  • NF-kappa B / genetics
  • NF-kappa B / metabolism*
  • Oxidation-Reduction
  • Oxidative Stress*
  • Reactive Oxygen Species
  • Sodium-Potassium-Exchanging ATPase / metabolism

Substances

  • Antioxidants
  • Detergents
  • NF-kappa B
  • Reactive Oxygen Species
  • Deoxycholic Acid
  • Cytochrome P-450 Enzyme System
  • NADPH Oxidases
  • Electron Transport Complex IV
  • Sodium-Potassium-Exchanging ATPase
  • Calcium